SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SLC29A2 antibody (Catalog #: ARP43822_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC29A2
(Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2))
Synonyme
DER12 Peptide, ENT2 Peptide, HNP36 Peptide, Der12 Peptide, Ent2 Peptide, Hnp36 Peptide, ent2 Peptide, der12 Peptide, hnp36 Peptide, MGC82995 Peptide, DKFZp468L038 Peptide, zgc:110527 Peptide, solute carrier family 29 member 2 Peptide, solute carrier family 29 (nucleoside transporters), member 2 Peptide, solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog Peptide, solute carrier family 29 (equilibrative nucleoside transporter), member 2 Peptide, SLC29A2 Peptide, Slc29a2 Peptide, slc29a2.L Peptide, slc29a2 Peptide
Hintergrund
SLC29A2 mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. It is less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.